0001104659-16-137597.txt : 20160805
0001104659-16-137597.hdr.sgml : 20160805
20160805160912
ACCESSION NUMBER: 0001104659-16-137597
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160803
FILED AS OF DATE: 20160805
DATE AS OF CHANGE: 20160805
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001454789
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-349-1971
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GALAKATOS NICHOLAS
CENTRAL INDEX KEY: 0001252522
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 161811232
MAIL ADDRESS:
STREET 1: THE JOHN HANCOCK TOWER
STREET 2: 200 CLARENDON STREET, 54TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
a4.xml
4
X0306
4
2016-08-03
0
0001454789
CATABASIS PHARMACEUTICALS INC
CATB
0001252522
GALAKATOS NICHOLAS
C/O CATABASIS PHARMACEUTICALS, INC.
ONE KENDALL SQ, BLDG 1400E, STE B14202
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (right to buy)
4.55
2016-08-03
4
A
0
6500
0
A
2026-08-02
Common Stock
6500
6500
D
This option was granted on August 3, 2016 and is scheduled to vest in full on June 15, 2017.
/s/ Andreas Matthews, as attorney-in-fact for Nicholas Galakatos
2016-08-05